Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non–small cell lung carcinoma
Journal of Pathology and Translational Medicine. 2021;55(4):279-288 
The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies
Diagnostic Pathology. 2019;14(1):
P2.09-12 EGFR Mutation Status in Squamous Cell Carcinoma or Non-Small Cell Carcinoma Favor Squamous Cell Carcinoma Diagnosed from Small Lung Biopsies
Journal of Thoracic Oncology. 2018;13(10):S765-S766
EGFR T790M resistance mutation in non small-cell lung carcinoma
Clinica Chimica Acta. 2015;444:81-85
Refining the Diagnosis and EGFR Status of Non-small Cell Lung Carcinoma in Biopsy and Cytologic Material, Using a Panel of Mucin Staining, TTF-1, Cytokeratin 5/6, and P63, and EGFR Mutation Analysis
Journal of Thoracic Oncology. 2010;5(4):436-441
Development of epidermal growth factor receptor tyrosine kinase inhibitors against EGFR T790M. Mutation in non small-cell lung carcinoma
Open Medicine. 2016;11(1):68-77
Afatinib in EGFR mutant non-small-cell carcinoma: Milton Keynes experience
Lung Cancer. 2020;139:S44
Erlotinib
Reactions Weekly. 2018;1717(1):129-129
EGFRmutation testing using archival-stained smears in non-small cell lung carcinoma
Cytopathology. 2016;28(1):35-45
60 Afatinib in EGFR mutation positive advanced non-small cell lung cancer
Lung Cancer. 2016;91:S22